November 22nd 2024
These findings further suggest the implications of acne vulgaris treatment on the skin barrier.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Top 10 dermatology stories of 2018
December 19th 2018Before 2018 comes to a close, we wanted to say thank you to our readers from everyone here at Dermatology Times. As a thank you, we have compiled a list of the topics and issues you found most compelling throughout the year. Enjoy this slideshow - and see you in 2019!
Sarecycline approved for moderate-to-severe acne
November 13th 2018The Food and Drug Administration (FDA) approved sarecycline (Seysara, Almirall, S.A.) in October for the treatment of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older, according to a company news release.
Ethical dilemmas for physicians in Catholic healthcare organizations
September 28th 2018Can clinicians working for Catholic health care organizations prescribe the birth control pill for acne? A recent article discusses the ethical and legal problems these clinicians face when patients request to be treated with oral contraceptives.
A low glycemic diet has the potential to reduce acne, study suggests
September 17th 2018A low glycemic index and glycemic load diet decreases IGF-1 concentrations, a well-established risk factor in the pathogenesis of acne pathogenesis indicating that such diets have the potential to reduce the impact of acne, a study suggests.
Are you equipped to identify depression in your acne patient?
August 13th 2018“As dermatologists, we are trained in managing acne. We can provide early and effective treatment that improves the physical and psychological effects. It is up to us to bridge the gap between those suffering from acne and their access to medical treatment."